By writer to www.healio.com
Healio Nephrology beforehand compiled an inventory of our high tales associated to the safe delivery of dialysis treatments through the COVID-19 pandemic.
Right here, we broaden the scope, together with tales on telenephrology; an artificial-intelligence primarily based instrument to foretell hostile occasions; spiking charges of acute kidney harm; and emergency assist from the HSS, the American Kidney Fund and main dialysis suppliers.
Visitor Commentary by Gaurav Jain, MD, and Eric Wallace, MD: COVID-19 and telenephrology: Classes to study from a world well being care disaster
Within the day-to-day battle of COVID-19, telehealth has emerged as an unlikely hero. Nevertheless, the main points of telehealth implementation and influence on workers and sufferers alike are nonetheless to be decided and are notably vital with respect to the care of nephrology sufferers.
The beneficiaries of telehealth applications are totally different primarily based on the implementation technique and focused purpose of the undertaking. Poor planning with out analyzing workers roles and views can have a long-lasting detrimental impact on the success of telehealth, whereas applications which might be deliberate and carried out with consideration might stand to vary the best way we observe nephrology ceaselessly. Read more.
Synthetic intelligence-based instrument being examined to foretell hostile kidney occasions in sufferers with COVID-19
The synthetic intelligence-enabled medical diagnostic for kidney illness, often known as KidneyIntelX, shall be utilized in a examine to find out its predictive capacity to evaluate the danger of hostile kidney occasions in sufferers identified with COVID-19. Read more.
In COVID-19 combat, AKI turns into new battle entrance
At Mt. Sinai Hospital in New York Metropolis, which accounts for greater than 10,000 deaths within the COVID-19 pandemic in the USA, Osama El Shamy, MD, works with different nephrologists and medical workers making an attempt to make sense of why a rising proportion of sufferers expertise acute kidney harm after being hospitalized.
“We’ve got had quite a lot of COVID-19 sufferers who develop AKI,” El Shamy, a third-year nephrology fellow at Sinai’s Icahn Faculty of Drugs, informed Nephrology Information & Points. “In a matter of days, we may even see a creatinine of 1 go to … as excessive as 13.” Read more.
HHS sends dialysis machines to hospitals with excessive circumstances of COVID-19; Fresenius ships gear from Europe
HHS has deployed 50 Tablo transportable kidney dialysis machines and provides to New York Metropolis and Lengthy Island ICUs caring for sufferers with COVID-19 who’ve additionally skilled acute kidney harm, in keeping with an company press launch.
The dialysis machines, made by Outset Medical, got here from the Strategic Nationwide Stockpile, which is managed by the Assistant Secretary for Preparedness and Response of HHS. HHS signed an settlement with Outset Medical in 2019 to supply dialysis machines throughout disasters. Read more.
Q&A: AKF president discusses COVID-19 emergency fund
On March 20, the American Kidney Fund launched a COVID-19 emergency fund to supply monetary help to low-income sufferers on dialysis or who’ve undergone kidney transplantation. The funding was shortly exhausted as a result of giant variety of functions the group acquired. After “interesting to firms, foundations and particular person donors to replenish the fund,” the AKF reported it has acquired donations from three firms. Read more.
Regardless of COVID-19 prices, DaVita to return $240 million from federal reduction fund
DaVita Inc. absorbed increased dialysis-related bills because of COVID-19 in March and April however has determined it should return roughly $240 million it secured from a federal authorities reduction fund geared toward serving to companies get better prices ensuing from the virus.
“DaVita has been and can be capable to proceed to supply look after our sufferers, together with the uninsured, with out the necessity for this federal funding,” DaVita Inc. CEO Javier J. Rodriguez mentioned throughout a Could 5 earnings name. Read more.
— to www.healio.com
